Skip to main content

Research Repository

Advanced Search

A randomised double-blind placebo-controlled trial to determine the safety and efficacy of inhaled SNG001 (IFN-β1a for nebulisation) for the treatment of patients with confirmed SARS-CoV-2 infection

People Involved

Status Project Complete
Value £28,094.00
Project Dates Apr 15, 2020 - Dec 31, 2022


You might also like

BE CLEAR: Development and refinement of a clinician consultation-aide intervention to support effective chronic breathlessness discussions with patients and their family carers Jul 1, 2025 - Dec 31, 2026
What is the problem?
Breathlessness is a frightening experience that stops people doing the things that are important to them. It is common, affecting nearly all people with long-term heart and lung conditions on most days.
However, clinicians do... Read More about BE CLEAR: Development and refinement of a clinician consultation-aide intervention to support effective chronic breathlessness discussions with patients and their family carers.